NOKOMIS, Fla.--(BUSINESS WIRE)-- <\/p>\n
With the regenerative medicine market expected by many analysts to explode in value to more than $35 billion by 2019, biotech innovators Rainbow Coral Corp. (RBCC) are targeting incredible new breakthroughs in the industry ripe for marketing and development. <\/p>\n
Forecasters across the globe are calling regenerative health the future of medicine, and with good reason. In recent years, major discoveries in the usage of adult stem cells and biologics have led to promising advances in the treatment of illnesses from chronic back pain to leukemia and even AIDS. <\/p>\n
With new, uniquely patentable regenerative therapies being developed all over the U.S., RBCC is reaching out to emerging industry leaders regarding development partnerships that could significantly boost the companys bottom line. <\/p>\n
So many current medical treatments focus on reducing pain and suffering rather than addressing their cause, said RBCC CEO Patrick Brown. A market revolution is now underway as new advances allow us increasingly to repair afflicted organs and systems using non-invasive methods. Its a new day in healthcare. <\/p>\n
By acquiring or partnering with up-and-coming regenerative therapy companies, RBCC plans to be well-positioned to capitalize on the big growth in store for the industry. The company invests in technology developed to compete in the biotechnology industry alongside Amgen (AMGN), Dendreon Corporation (DNDN), Smith & Nephew (SNN) and Pharmaceutical Product Development (NASDAQ:PPDI). <\/p>\n
For more information on RBCCs other biotech initiatives, please visitwww.rainbowbiosciences.com. <\/p>\n
About Rainbow Biosciences <\/p>\n
Rainbow Biosciences, LLC, is a wholly owned subsidiary of Rainbow Coral Corp. (OTCBB:RBCC). The Company continually seeks out new partnerships with biotechnology developers to deliver profitable new medical technologies and innovations. For more information on our growth-oriented business initiatives, please visitwww.RainbowBioSciences.com. For investment information and performance data on the Company, please visitwww.RainbowBioSciences.com\/investors.html. <\/p>\n
Notice Regarding Forward-Looking Statements <\/p>\n
<\/p>\n
See more here:<\/p>\n
RBCC Explores Promising New Breakthroughs in Regenerative Medicine<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" NOKOMIS, Fla.--(BUSINESS WIRE)-- With the regenerative medicine market expected by many analysts to explode in value to more than $35 billion by 2019, biotech innovators Rainbow Coral Corp. (RBCC) are targeting incredible new breakthroughs in the industry ripe for marketing and development Continue reading